Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 150 | $65,350,206 |
Sells | 481 | $783,149,072 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 Jun 2024 21:24 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 17 Jun 2024 | Sale | 2,134 | 1.2835 | 2,739 | D |
18 Jun 2024 21:25 | BTAI | BioXcel Therapeutics Inc | O'NEILL VINCENT | See Remarks | 17 Jun 2024 | Sale | 155 | 1.285 | 199 | D |
18 Jun 2024 21:25 | BTAI | BioXcel Therapeutics Inc | RODRIGUEZ JAVIER | See Remarks | 17 Jun 2024 | Sale | 361 | 1.2632 | 456 | D |
18 Jun 2024 21:26 | BTAI | BioXcel Therapeutics Inc | STEINHART RICHARD I | Chief Financial Officer | 17 Jun 2024 | Sale | 372 | 1.2622 | 470 | D |
18 Jun 2024 21:26 | BTAI | BioXcel Therapeutics Inc | WILEY MATTHEW T. | Chief Commercial Officer | 17 Jun 2024 | Sale | 244 | 1.2627 | 308 | D |
18 Jun 2024 21:27 | BTAI | BioXcel Therapeutics Inc | YOCCA FRANK | Chief Scientific Officer | 17 Jun 2024 | Sale | 372 | 1.28 | 476 | D |
18 Jun 2024 21:35 | NTRA | Natera Inc | CHAPMAN STEVEN LEONARD | CEO AND PRESIDENT | 17 Jun 2024 | Sale | 1,247 | 112.5498 | 140,350 | D |
18 Jun 2024 21:35 | NTRA | Natera Inc | CHAPMAN STEVEN LEONARD | CEO AND PRESIDENT | 17 Jun 2024 | Sale | 3,243 | 111.8751 | 362,811 | D |
18 Jun 2024 21:35 | NTRA | Natera Inc | CHAPMAN STEVEN LEONARD | CEO AND PRESIDENT | 17 Jun 2024 | Sale | 1,615 | 110.3475 | 178,211 | D |
18 Jun 2024 21:35 | ADCT | ADC Therapeutics SA | SQUARER RON | Director | 17 Jun 2024 | Sale | 6,995 | 2.89 | 20,216 | D |
18 Jun 2024 21:37 | ADCT | ADC Therapeutics SA | SANDOR VICTOR | Director | 17 Jun 2024 | Sale | 6,995 | 2.89 | 20,216 | D |
18 Jun 2024 21:38 | ADCT | ADC Therapeutics SA | PFISTERER THOMAS | Director | 17 Jun 2024 | Sale | 1,437 | 2.89 | 4,153 | D |
18 Jun 2024 21:39 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Jun 2024 | Sale | 1,900 | 280 | 532,000 | D |
18 Jun 2024 21:40 | ADCT | ADC Therapeutics SA | MONGES VIVIANE | Director | 17 Jun 2024 | Sale | 1,437 | 2.89 | 4,153 | D |
18 Jun 2024 21:41 | ADCT | ADC Therapeutics SA | HUG PETER | Director | 17 Jun 2024 | Sale | 1,193 | 2.89 | 3,448 | D |
18 Jun 2024 21:43 | ADCT | ADC Therapeutics SA | BIZZARI JEAN-PIERRE | Director | 17 Jun 2024 | Sale | 6,995 | 2.89 | 20,216 | D |
18 Jun 2024 21:44 | EXFY | Expensify Inc | MURALIDHARAN ANURADHA | Chief Operating Officer | 17 Jun 2024 | Sale | 2,682 | 1.34 | 3,594 | D |
18 Jun 2024 21:44 | EXFY | Expensify Inc | BARRETT DAVID MICHAEL | Chief Executive Officer | 18 Jun 2024 | Sale | 18,730 | 1.3 | 24,349 | I |
18 Jun 2024 21:44 | EXFY | Expensify Inc | BARRETT DAVID MICHAEL | Chief Executive Officer | 17 Jun 2024 | Sale | 17,940 | 1.37 | 24,578 | I |
18 Jun 2024 21:44 | EXFY | Expensify Inc | BARRETT DAVID MICHAEL | Chief Executive Officer | 17 Jun 2024 | Sale | 11,072 | 1.34 | 14,836 | D |
18 Jun 2024 21:44 | EXFY | Expensify Inc | BARRETT DAVID MICHAEL | Chief Executive Officer | 14 Jun 2024 | Sale | 17,740 | 1.38 | 24,481 | I |
18 Jun 2024 21:45 | EXFY | Expensify Inc | VIDAL DANIEL | Director | 17 Jun 2024 | Sale | 1,653 | 1.34 | 2,215 | D |
18 Jun 2024 21:45 | EXFY | Expensify Inc | SCHAFFER RYAN | Chief Financial Officer | 17 Jun 2024 | Sale | 2,443 | 1.34 | 3,274 | D |
18 Jun 2024 21:45 | EXFY | Expensify Inc | MILLS JASON FAHR | Director | 17 Jun 2024 | Sale | 1,955 | 1.34 | 2,620 | D |
18 Jun 2024 21:45 | ADCT | ADC Therapeutics SA | AZELBY ROBERT | Director | 17 Jun 2024 | Sale | 6,995 | 2.89 | 20,216 | D |
18 Jun 2024 21:47 | NTNX | Nutanix Inc | SIVARAMAN RUKMINI | Chief Financial Officer | 18 Jun 2024 | Sale | 419 | 54.53 | 22,848 | D |
18 Jun 2024 21:47 | NTNX | Nutanix Inc | SIVARAMAN RUKMINI | Chief Financial Officer | 18 Jun 2024 | Sale | 12,147 | 53.1769 | 645,940 | D |
18 Jun 2024 21:49 | NTNX | Nutanix Inc | SANGSTER DAVID | Chief Operating Officer | 18 Jun 2024 | Sale | 347 | 54.53 | 18,922 | D |
18 Jun 2024 21:49 | NTNX | Nutanix Inc | SANGSTER DAVID | Chief Operating Officer | 18 Jun 2024 | Sale | 10,037 | 54.1734 | 543,738 | D |
18 Jun 2024 21:50 | NTNX | Nutanix Inc | RAMASWAMI RAJIV | President and CEO | 18 Jun 2024 | Sale | 1,162 | 54.5181 | 63,350 | D |
18 Jun 2024 21:50 | NTNX | Nutanix Inc | RAMASWAMI RAJIV | President and CEO | 18 Jun 2024 | Sale | 22,824 | 54.1705 | 1,236,387 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)